ClinicalTrials.gg
RecruitingNCT07164456Updated Mar 9, 2026

Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers

An interventional study of Education sessions and Questionnaire in Family Centered, Black Ethnicity and Prostate Cancer Survivors, sponsored by M.D. Anderson Cancer Center. Recruiting at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by M.D. Anderson Cancer Center · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
648
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 124 studies in Prostatic Neoplasms by M.D. Anderson Cancer Center — 22 open to participants now, 40 under way, 3 of them phase 3. Prostatic Neoplasms · M.D. Anderson Cancer Center.

Planned enrollment
Largest of 106
648 · median 41
Started
2026
with 3 others
No phase
25 of 124
8 open now
Primary completion
2031-06
later than 39 of 39 live
Registered
121st of 124
by date

Among the 124 studies in Prostatic Neoplasms by M.D. Anderson Cancer Center, this one has the largest planned enrollment of the 106 interventional ones that give a count, is one of 4 that started in 2026, is one of 25 with no phase, reaches primary completion later than 39 of the 39 other live ones, and was the 121st registered.

Prostatic Neoplasms

7,058 studies on the registry are indexed under Prostatic Neoplasms; 1,582 are open to participants now.

Browse Prostatic Neoplasms studies →

Open to participants now

22 of the 124 studies in Prostatic Neoplasms by M.D. Anderson Cancer Center are open now, in 1 country. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

Where they have run

Who these studies take

Of the 1,236 Prostatic Neoplasms studies recruiting now, 933 (75%) set no upper age limit and 77 (6%) stop at 75 or younger; 67 take children under 18; 82 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 124 studies in Prostatic Neoplasms by M.D. Anderson Cancer Center, or all of them as a file.
02

Study summary

To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate, compared to survivor-only and control groups.

Read the detailed description

Primary Objectives

  • Determine the extent to which MVPA and overall diet quality have improved in Black PCa survivors and their caregivers in the family-centered intervention group, compared to those in the survivor-only and control groups at post-intervention.

Secondary Objectives

  • Determine the extent to which, compared to those in the survivor-only and control groups, both survivors and caregivers in the family-centered group maintain the MVPA and high diet quality at the 6-month follow-up, and experience improved 6MWT, QoL, and family health climate at both post-intervention and 6-month follow-up.
  • Identify mediators and moderators of the family-centered intervention.
03

Conditions studied

  • Family Centered
  • Black Ethnicity
  • Prostate Cancer Survivors

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Eligibility Criteria

Survivors are eligible if they

  • Are adults (≥18 years old)
  • Self-identify as Black or African American;
  • Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q); and
  • Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included.

Caregivers are eligible if they:

  • Are adults (≥18 years old)
  • Are able to be physically active, as determined by responses to the

Exclusion Criteria

Survivors are excluded if they:

  • Have a prior history of other cancer or have cancer.
  • Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period.
  • Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a lifestyle or weight management program.

Caregivers are excluded if they:

  • Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
  • Are currently participating in a lifestyle or weight management program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
648 participants (estimated)

Study arms

  • Experimental
    Family-centered intervention

    Includes a nutrition education session, a PA education session, and 12 health-coaching calls, all conducted via Zoom or phone.

    Other: Education sessions · Other: Questionnaire

  • Experimental
    survivor-only intervention

    Includes a nutrition education session, a PA education session, and 12 health-coaching calls, all conducted via Zoom or phone.

    Other: Education sessions · Other: Questionnaire

  • Experimental
    Health education control

    Will focus on enhancing participants' intrinsic motivation and problem-solving skills related to improving diet quality and engaging in PA. A total of 12 sessions will be provided, with approximately 2 sessions per month

    Other: Education sessions · Other: Questionnaire

Interventions

  • OtherEducation sessions

    Remote and In person sessions

  • OtherQuestionnaire

    Questionnaires given a 3,6,12 mouth follow ups

06

What researchers measure

Primary outcomes

  1. Physical Activity Readiness Questionnaire

    Time frame: Through study completion; an average of 1 year

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jun 2031, 65 months after the start.

Of 1,104 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 87. This study's planned 65 months is above that.

Counting every sponsor, half of 1,162 studies reached it within 43 months; a quarter within 22 and three quarters within 86.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2025
First posted
Sep 10, 2025
StartActual
Jan 13, 2026
Primary completionEst.
Jun 30, 2031
CompletionEst.
Jun 30, 2033
Last update
Mar 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07164456
Responsible party
Sponsor
First posted
Sep 10, 2025
Start date
Jan 13, 2026
Primary completion
Jun 30, 2031 (estimated)
Completion
Jun 30, 2033 (estimated)
Last update
Mar 9, 2026

Study contacts

Dalnim Cho, MD
Contact
dcho1@mdanderson.org
713-745-8476
Dalnim Cho, MD
principal investigator · MD Andersson Cancer Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion